[Preliminary studies on the use of LB 46--a new agent from the group of beta-adrenergic inhibitors].
D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000008:administration & dosage* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D006801:Humans
D000605:Amino Alcohols
Wstepne badania nad stosowaniem LB 46 nowego leku z grupy beta-blokerów.